KORU Medical Systems Inc KRMD.OQ KRMD.O is expected to show a rise in quarterly revenue when it reports results on March 12 for the period ending December 31 2024
The Mahwah New Jersey-based company is expected to report a 23.8% increase in revenue to $8.893 million from $7.19 million a year ago, according to the mean estimate from 5 analysts, based on LSEG data.
LSEG's mean analyst estimate for KORU Medical Systems Inc is for a loss of 3 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for KORU Medical Systems Inc is $6.00, above its last closing price of $3.16.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Sep. 30 2024 | -0.03 | -0.04 | -0.03 | Beat | 21.1 |
Jun. 30 2024 | -0.05 | -0.04 | -0.02 | Beat | 52.4 |
Mar. 31 2024 | -0.04 | -0.04 | -0.02 | Beat | 47.4 |
Dec. 31 2023 | -0.05 | -0.04 | -0.03 | Beat | 25 |
Sep. 30 2023 | -0.06 | -0.05 | -0.03 | Beat | 40 |
Jun. 30 2023 | -0.06 | -0.06 | -0.05 | Beat | 11.8 |
Mar. 31 2023 | -0.04 | -0.05 | -0.05 | Met | 0 |
Dec. 31 2022 | -0.06 | -0.06 | -0.04 | Beat | 29.4 |
This summary was machine generated March 10 at 20:14 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Comments